Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 53 entries
Sorted by: Best Match Show Resources per page
Rapid Decline in Vaccine-induced Anti-SARS-CoV-2 Antibody Titers 3 Months After Kidney Transplantation: A Case Series From Belgium.

Transplantation

Fernandes G, Devresse A, Scohy A, Yombi JC, Belkhir L, De Greef J, De Meyer M, Mourad M, Darius T, Buemi A, Kabamba B, Goffin E, Kanaan N.
PMID: 34581313
Transplantation. 2022 Jan 01;106(1):e98-e99. doi: 10.1097/TP.0000000000003963.

No abstract available.

Cite
Fernandes G, Devresse A, Scohy A, et al. Rapid Decline in Vaccine-induced Anti-SARS-CoV-2 Antibody Titers 3 Months After Kidney Transplantation: A Case Series From Belgium. Transplantation. 2022;106(1):e98-e99doi: 10.1097/TP.0000000000003963.
Fernandes, G., Devresse, A., Scohy, A., Yombi, J. C., Belkhir, L., De Greef, J., De Meyer, M., Mourad, M., Darius, T., Buemi, A., Kabamba, B., Goffin, E., & Kanaan, N. (2022). Rapid Decline in Vaccine-induced Anti-SARS-CoV-2 Antibody Titers 3 Months After Kidney Transplantation: A Case Series From Belgium. Transplantation, 106(1), e98-e99. https://doi.org/10.1097/TP.0000000000003963
Fernandes, Guillaume, et al. "Rapid Decline in Vaccine-induced Anti-SARS-CoV-2 Antibody Titers 3 Months After Kidney Transplantation: A Case Series From Belgium." Transplantation vol. 106,1 (2022): e98-e99. doi: https://doi.org/10.1097/TP.0000000000003963
Fernandes G, Devresse A, Scohy A, Yombi JC, Belkhir L, De Greef J, De Meyer M, Mourad M, Darius T, Buemi A, Kabamba B, Goffin E, Kanaan N. Rapid Decline in Vaccine-induced Anti-SARS-CoV-2 Antibody Titers 3 Months After Kidney Transplantation: A Case Series From Belgium. Transplantation. 2022 Jan 01;106(1):e98-e99. doi: 10.1097/TP.0000000000003963. PMID: 34581313; PMCID: PMC8667679.
Copy Download .nbib Format: NLM
Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases.

The Journal of infection

Manolache NG, Ursachi V, Scohy A, Desmet C, Yombi JC, Toukap AN, Stoenoiu MS.
PMID: 34920024
J Infect. 2021 Dec 14; doi: 10.1016/j.jinf.2021.12.006. Epub 2021 Dec 14.

No abstract available.

Cite
Manolache NG, Ursachi V, Scohy A, et al. Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases. J Infect. 2021;doi: 10.1016/j.jinf.2021.12.006.
Manolache, N. G., Ursachi, V., Scohy, A., Desmet, C., Yombi, J. C., Toukap, A. N., & Stoenoiu, M. S. (2021). Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases. The Journal of infection, . https://doi.org/10.1016/j.jinf.2021.12.006
Manolache, N G, et al. "Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases." The Journal of infection vol. (2021). doi: https://doi.org/10.1016/j.jinf.2021.12.006
Manolache NG, Ursachi V, Scohy A, Desmet C, Yombi JC, Toukap AN, Stoenoiu MS. Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases. J Infect. 2021 Dec 14; doi: 10.1016/j.jinf.2021.12.006. Epub 2021 Dec 14. PMID: 34920024; PMCID: PMC8673932.
Copy Download .nbib Format: NLM
Outbreak of hepatitis B and hepatitis C virus infections associated with a cardiology clinic, West Virginia, 2012-2014.

Infection control and hospital epidemiology

Tressler SR, Del Rosario MC, Kirby MD, Simmons AN, Scott MA, Ibrahim S, Forbi JC, Thai H, Xia GL, Lyman M, Collier MG, Patel PR, Bixler D.
PMID: 33641684
Infect Control Hosp Epidemiol. 2021 Dec;42(12):1458-1463. doi: 10.1017/ice.2021.31. Epub 2021 Mar 01.

OBJECTIVE: To stop transmission of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in association with myocardial perfusion imaging (MPI) at a cardiology clinic.DESIGN: Outbreak investigation and quasispecies analysis of HCV hypervariable region 1 genome.SETTING: Outpatient cardiology...

Cite
Tressler SR, Del Rosario MC, Kirby MD, et al. Outbreak of hepatitis B and hepatitis C virus infections associated with a cardiology clinic, West Virginia, 2012-2014. Infect Control Hosp Epidemiol. 2021;42(12):1458-1463doi: 10.1017/ice.2021.31.
Tressler, S. R., Del Rosario, M. C., Kirby, M. D., Simmons, A. N., Scott, M. A., Ibrahim, S., Forbi, J. C., Thai, H., Xia, G. L., Lyman, M., Collier, M. G., Patel, P. R., & Bixler, D. (2021). Outbreak of hepatitis B and hepatitis C virus infections associated with a cardiology clinic, West Virginia, 2012-2014. Infection control and hospital epidemiology, 42(12), 1458-1463. https://doi.org/10.1017/ice.2021.31
Tressler, Stacy R, et al. "Outbreak of hepatitis B and hepatitis C virus infections associated with a cardiology clinic, West Virginia, 2012-2014." Infection control and hospital epidemiology vol. 42,12 (2021): 1458-1463. doi: https://doi.org/10.1017/ice.2021.31
Tressler SR, Del Rosario MC, Kirby MD, Simmons AN, Scott MA, Ibrahim S, Forbi JC, Thai H, Xia GL, Lyman M, Collier MG, Patel PR, Bixler D. Outbreak of hepatitis B and hepatitis C virus infections associated with a cardiology clinic, West Virginia, 2012-2014. Infect Control Hosp Epidemiol. 2021 Dec;42(12):1458-1463. doi: 10.1017/ice.2021.31. Epub 2021 Mar 01. PMID: 33641684.
Copy Download .nbib Format: NLM
Validation of Neutrophil-to-Lymphocyte Ratio Cut-off Value Associated with High In-Hospital Mortality in COVID-19 Patients.

International journal of general medicine

Yildiz H, Castanares-Zapatero D, Pierman G, Pothen L, De Greef J, Aboubakar Nana F, Rodriguez-Villalobos H, Belkhir L, Yombi JC.
PMID: 34511993
Int J Gen Med. 2021 Sep 01;14:5111-5117. doi: 10.2147/IJGM.S326666. eCollection 2021.

INTRODUCTION: The neutrophil-to-lymphocyte ratio (NLR) could be a predictive factor of severe COVID-19. However, most relevant studies are retrospective, and the optimal NLR cut-off point has not been determined. The objective of our research was identification and validation of...

Cite
Yildiz H, Castanares-Zapatero D, Pierman G, et al. Validation of Neutrophil-to-Lymphocyte Ratio Cut-off Value Associated with High In-Hospital Mortality in COVID-19 Patients. Int J Gen Med. 2021;14:5111-5117doi: 10.2147/IJGM.S326666.
Yildiz, H., Castanares-Zapatero, D., Pierman, G., Pothen, L., De Greef, J., Aboubakar Nana, F., Rodriguez-Villalobos, H., Belkhir, L., & Yombi, J. C. (2021). Validation of Neutrophil-to-Lymphocyte Ratio Cut-off Value Associated with High In-Hospital Mortality in COVID-19 Patients. International journal of general medicine, 145111-5117. https://doi.org/10.2147/IJGM.S326666
Yildiz, Halil, et al. "Validation of Neutrophil-to-Lymphocyte Ratio Cut-off Value Associated with High In-Hospital Mortality in COVID-19 Patients." International journal of general medicine vol. 14 (2021): 5111-5117. doi: https://doi.org/10.2147/IJGM.S326666
Yildiz H, Castanares-Zapatero D, Pierman G, Pothen L, De Greef J, Aboubakar Nana F, Rodriguez-Villalobos H, Belkhir L, Yombi JC. Validation of Neutrophil-to-Lymphocyte Ratio Cut-off Value Associated with High In-Hospital Mortality in COVID-19 Patients. Int J Gen Med. 2021 Sep 01;14:5111-5117. doi: 10.2147/IJGM.S326666. eCollection 2021. PMID: 34511993; PMCID: PMC8420786.
Copy Download .nbib Format: NLM
Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases.

The Journal of infection

Manolache NG, Ursachi V, Scohy A, Desmet C, Yombi JC, Toukap AN, Stoenoiu MS.
PMID: 34920024
J Infect. 2021 Dec 14; doi: 10.1016/j.jinf.2021.12.006. Epub 2021 Dec 14.

No abstract available.

Cite
Manolache NG, Ursachi V, Scohy A, et al. Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases. J Infect. 2021;doi: 10.1016/j.jinf.2021.12.006.
Manolache, N. G., Ursachi, V., Scohy, A., Desmet, C., Yombi, J. C., Toukap, A. N., & Stoenoiu, M. S. (2021). Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases. The Journal of infection, . https://doi.org/10.1016/j.jinf.2021.12.006
Manolache, N G, et al. "Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases." The Journal of infection vol. (2021). doi: https://doi.org/10.1016/j.jinf.2021.12.006
Manolache NG, Ursachi V, Scohy A, Desmet C, Yombi JC, Toukap AN, Stoenoiu MS. Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases. J Infect. 2021 Dec 14; doi: 10.1016/j.jinf.2021.12.006. Epub 2021 Dec 14. PMID: 34920024; PMCID: PMC8673932.
Copy Download .nbib Format: NLM
How to manage surgical patients during and early after COVID-19 pandemic: a practical approach for low-and middle-income countries (LMICs).

The Pan African medical journal

Ngatchou W, Temgoua MN, Tochie JN, Betou FSA, Yombi JC, Lemogoum D.
PMID: 33623593
Pan Afr Med J. 2020 Jun 09;35:69. doi: 10.11604/pamj.supp.2020.35.2.23681. eCollection 2020.

No abstract available.

Cite
Ngatchou W, Temgoua MN, Tochie JN, et al. How to manage surgical patients during and early after COVID-19 pandemic: a practical approach for low-and middle-income countries (LMICs). Pan Afr Med J. 2020;35:69doi: 10.11604/pamj.supp.2020.35.2.23681.
Ngatchou, W., Temgoua, M. N., Tochie, J. N., Betou, F. S. A., Yombi, J. C., & Lemogoum, D. (2020). How to manage surgical patients during and early after COVID-19 pandemic: a practical approach for low-and middle-income countries (LMICs). The Pan African medical journal, 3569. https://doi.org/10.11604/pamj.supp.2020.35.2.23681
Ngatchou, William, et al. "How to manage surgical patients during and early after COVID-19 pandemic: a practical approach for low-and middle-income countries (LMICs)." The Pan African medical journal vol. 35 (2020): 69. doi: https://doi.org/10.11604/pamj.supp.2020.35.2.23681
Ngatchou W, Temgoua MN, Tochie JN, Betou FSA, Yombi JC, Lemogoum D. How to manage surgical patients during and early after COVID-19 pandemic: a practical approach for low-and middle-income countries (LMICs). Pan Afr Med J. 2020 Jun 09;35:69. doi: 10.11604/pamj.supp.2020.35.2.23681. eCollection 2020. PMID: 33623593; PMCID: PMC7875807.
Copy Download .nbib Format: NLM
Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies.

Therapeutics and clinical risk management

Yildiz H, Bailly S, Van Den Neste E, Yombi JC.
PMID: 33888986
Ther Clin Risk Manag. 2021 Apr 14;17:293-304. doi: 10.2147/TCRM.S195538. eCollection 2021.

INTRODUCTION: Haemophagocytic lymphohistiocytosis (HLH) is a severe disorder with high mortality. The aim of this review is to update clinical management of relapsed/refractory HLH in adults, with a focus on current and new therapies.METHODS: We searched relevant articles in...

Cite
Yildiz H, Bailly S, Van Den Neste E, et al. Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies. Ther Clin Risk Manag. 2021;17:293-304doi: 10.2147/TCRM.S195538.
Yildiz, H., Bailly, S., Van Den Neste, E., & Yombi, J. C. (2021). Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies. Therapeutics and clinical risk management, 17293-304. https://doi.org/10.2147/TCRM.S195538
Yildiz, Halil, et al. "Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies." Therapeutics and clinical risk management vol. 17 (2021): 293-304. doi: https://doi.org/10.2147/TCRM.S195538
Yildiz H, Bailly S, Van Den Neste E, Yombi JC. Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies. Ther Clin Risk Manag. 2021 Apr 14;17:293-304. doi: 10.2147/TCRM.S195538. eCollection 2021. PMID: 33888986; PMCID: PMC8056168.
Copy Download .nbib Format: NLM
Rapid Decline in Vaccine-induced Anti-SARS-CoV-2 Antibody Titers 3 Months After Kidney Transplantation: A Case Series From Belgium.

Transplantation

Fernandes G, Devresse A, Scohy A, Yombi JC, Belkhir L, De Greef J, De Meyer M, Mourad M, Darius T, Buemi A, Kabamba B, Goffin E, Kanaan N.
PMID: 34581313
Transplantation. 2022 Jan 01;106(1):e98-e99. doi: 10.1097/TP.0000000000003963.

No abstract available.

Cite
Fernandes G, Devresse A, Scohy A, et al. Rapid Decline in Vaccine-induced Anti-SARS-CoV-2 Antibody Titers 3 Months After Kidney Transplantation: A Case Series From Belgium. Transplantation. 2022;106(1):e98-e99doi: 10.1097/TP.0000000000003963.
Fernandes, G., Devresse, A., Scohy, A., Yombi, J. C., Belkhir, L., De Greef, J., De Meyer, M., Mourad, M., Darius, T., Buemi, A., Kabamba, B., Goffin, E., & Kanaan, N. (2022). Rapid Decline in Vaccine-induced Anti-SARS-CoV-2 Antibody Titers 3 Months After Kidney Transplantation: A Case Series From Belgium. Transplantation, 106(1), e98-e99. https://doi.org/10.1097/TP.0000000000003963
Fernandes, Guillaume, et al. "Rapid Decline in Vaccine-induced Anti-SARS-CoV-2 Antibody Titers 3 Months After Kidney Transplantation: A Case Series From Belgium." Transplantation vol. 106,1 (2022): e98-e99. doi: https://doi.org/10.1097/TP.0000000000003963
Fernandes G, Devresse A, Scohy A, Yombi JC, Belkhir L, De Greef J, De Meyer M, Mourad M, Darius T, Buemi A, Kabamba B, Goffin E, Kanaan N. Rapid Decline in Vaccine-induced Anti-SARS-CoV-2 Antibody Titers 3 Months After Kidney Transplantation: A Case Series From Belgium. Transplantation. 2022 Jan 01;106(1):e98-e99. doi: 10.1097/TP.0000000000003963. PMID: 34581313; PMCID: PMC8667679.
Copy Download .nbib Format: NLM
[Stomato-oncological screening examinations: possibilities for early diagnosis].

Magyar onkologia

Bánóczy J, Bakó A, Dombi C, Ember I, Kósa Z, Sándor J, Szabó G.
PMID: 12050708
Magy Onkol. 2001;45(2):143-148. doi: HUON.2001.45.2.0143.

The dramatic increase in the mortality of lip- and oral cancers in Hungary in the last decades points to the importance of primary and secondary prevention. Stomato-oncological screening examinations belong to the latter category, and might represent useful tools...

Cite
Bánóczy J, Bakó A, Dombi C, et al. Stomato-onkológiai szûrôvizsgálatok: a korai diagnosis lehetôségei. [Stomato-oncological screening examinations: possibilities for early diagnosis]. Magy Onkol. 2001;45(2):143-148doi: HUON.2001.45.2.0143.
Bánóczy, J., Bakó, A., Dombi, C., Ember, I., Kósa, Z., Sándor, J., & Szabó, G. (2001). Stomato-onkológiai szûrôvizsgálatok: a korai diagnosis lehetôségei. [Stomato-oncological screening examinations: possibilities for early diagnosis]. Magyar onkologia, 45(2), 143-148. https://doi.org/HUON.2001.45.2.0143
Bánóczy, J, et al. "Stomato-onkológiai szûrôvizsgálatok: a korai diagnosis lehetôségei." [Stomato-oncological screening examinations: possibilities for early diagnosis]. Magyar onkologia vol. 45,2 (2001): 143-148. doi: https://doi.org/HUON.2001.45.2.0143
Bánóczy J, Bakó A, Dombi C, Ember I, Kósa Z, Sándor J, Szabó G. Stomato-onkológiai szûrôvizsgálatok: a korai diagnosis lehetôségei. [Stomato-oncological screening examinations: possibilities for early diagnosis]. Magy Onkol. 2001;45(2):143-148. doi: HUON.2001.45.2.0143. Hungarian. PMID: 12050708.
Copy Download .nbib Format: NLM
Breast Cancer Profile in a Group of Patients Followed up at the Radiation Therapy Unit of the Yaounde General Hospital, Cameroon.

Obstetrics and gynecology international

Kemfang Ngowa JD, Yomi J, Kasia JM, Mawamba Y, Ekortarh AC, Vlastos G.
PMID: 21785601
Obstet Gynecol Int. 2011;2011:143506. doi: 10.1155/2011/143506. Epub 2011 Jul 18.

Objective. To describe the profile of breast cancer in the patients attending the radiation therapy unit of Yaounde General Hospital. Method. From 1989 to 2009, we conducted a descriptive retrospective study based on the register and medical records of...

Cite
Kemfang Ngowa JD, Yomi J, Kasia JM, et al. Breast Cancer Profile in a Group of Patients Followed up at the Radiation Therapy Unit of the Yaounde General Hospital, Cameroon. Obstet Gynecol Int. 2011;2011:143506doi: 10.1155/2011/143506.
Kemfang Ngowa, J. D., Yomi, J., Kasia, J. M., Mawamba, Y., Ekortarh, A. C., & Vlastos, G. (2011). Breast Cancer Profile in a Group of Patients Followed up at the Radiation Therapy Unit of the Yaounde General Hospital, Cameroon. Obstetrics and gynecology international, 2011143506. https://doi.org/10.1155/2011/143506
Kemfang Ngowa, J D, et al. "Breast Cancer Profile in a Group of Patients Followed up at the Radiation Therapy Unit of the Yaounde General Hospital, Cameroon." Obstetrics and gynecology international vol. 2011 (2011): 143506. doi: https://doi.org/10.1155/2011/143506
Kemfang Ngowa JD, Yomi J, Kasia JM, Mawamba Y, Ekortarh AC, Vlastos G. Breast Cancer Profile in a Group of Patients Followed up at the Radiation Therapy Unit of the Yaounde General Hospital, Cameroon. Obstet Gynecol Int. 2011;2011:143506. doi: 10.1155/2011/143506. Epub 2011 Jul 18. PMID: 21785601; PMCID: PMC3140033.
Copy Download .nbib Format: NLM
Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases.

The Journal of infection

Manolache NG, Ursachi V, Scohy A, Desmet C, Yombi JC, Toukap AN, Stoenoiu MS.
PMID: 34920024
J Infect. 2021 Dec 14; doi: 10.1016/j.jinf.2021.12.006. Epub 2021 Dec 14.

No abstract available.

Cite
Manolache NG, Ursachi V, Scohy A, et al. Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases. J Infect. 2021;doi: 10.1016/j.jinf.2021.12.006.
Manolache, N. G., Ursachi, V., Scohy, A., Desmet, C., Yombi, J. C., Toukap, A. N., & Stoenoiu, M. S. (2021). Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases. The Journal of infection, . https://doi.org/10.1016/j.jinf.2021.12.006
Manolache, N G, et al. "Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases." The Journal of infection vol. (2021). doi: https://doi.org/10.1016/j.jinf.2021.12.006
Manolache NG, Ursachi V, Scohy A, Desmet C, Yombi JC, Toukap AN, Stoenoiu MS. Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases. J Infect. 2021 Dec 14; doi: 10.1016/j.jinf.2021.12.006. Epub 2021 Dec 14. PMID: 34920024.
Copy Download .nbib Format: NLM
Cellular response to COVID-19 vaccines in hematologic malignancies patients: a new hope for non-responders?.

Leukemia & lymphoma

Saad Albichr I, De Greef J, Van Den Neste E, Poiré X, Havelange V, Vekemans MC, Bailly S, Yombi JC, Mzougui S, Scohy A, Kabamba-Mukadi B.
PMID: 34706604
Leuk Lymphoma. 2021 Oct 28;1-4. doi: 10.1080/10428194.2021.1998485. Epub 2021 Oct 28.

No abstract available.

Cite
Saad Albichr I, De Greef J, Van Den Neste E, et al. Cellular response to COVID-19 vaccines in hematologic malignancies patients: a new hope for non-responders?. Leuk Lymphoma. 2021;1-4doi: 10.1080/10428194.2021.1998485.
Saad Albichr, I., De Greef, J., Van Den Neste, E., Poiré, X., Havelange, V., Vekemans, M. C., Bailly, S., Yombi, J. C., Mzougui, S., Scohy, A., & Kabamba-Mukadi, B. (2021). Cellular response to COVID-19 vaccines in hematologic malignancies patients: a new hope for non-responders?. Leukemia & lymphoma, 1-4. https://doi.org/10.1080/10428194.2021.1998485
Saad Albichr, Imane, et al. "Cellular response to COVID-19 vaccines in hematologic malignancies patients: a new hope for non-responders?." Leukemia & lymphoma vol. (2021): 1-4. doi: https://doi.org/10.1080/10428194.2021.1998485
Saad Albichr I, De Greef J, Van Den Neste E, Poiré X, Havelange V, Vekemans MC, Bailly S, Yombi JC, Mzougui S, Scohy A, Kabamba-Mukadi B. Cellular response to COVID-19 vaccines in hematologic malignancies patients: a new hope for non-responders?. Leuk Lymphoma. 2021 Oct 28;1-4. doi: 10.1080/10428194.2021.1998485. Epub 2021 Oct 28. PMID: 34706604; PMCID: PMC8567276.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 53 entries